Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome Prices IPO at 7.5 Euros per Share; Will Start Trading on Eurolist Tomorrow

NEW YORK, June 26 (GenomeWeb News) - OncoMethylome Sciences has priced its initial public offering at €7.50 ($9.44) per share and will begin trading on the Eurolist exchange in Brussels and Amsterdam tomorrow, the company said today.


The company said that it expects to raise €22 million ($27.7 million) by issuing 2,933,334 new shares. It could raise up to €25 million if a 15 percent over-allotment option is exercised in full.


Approximately 12 percent of the shares will be allocated to retail investors in Belgium and The Netherlands and the remaining shares will be allocated to institutional investors in Belgium, The Netherlands, and elsewhere in Europe.


OncoMethylome Sciences, which is developing diagnostics based on DNA methylation patterns, will be listed under the ticker symbol ONCOB by Euronext Brussels and under the ticker symbol ONCOA by Euronext Amsterdam.


The company is based in Liège, Belgium, and has a development team in Amsterdam.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.